NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. - Wikidata - awgldk - TriplyDB

NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.

NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.

http://www.wikidata.org/entity/Q37018606

about

Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications

P2860

Q37641718-4850E5E8-006D-4C4A-8832-E7B8F173CD15 Q57107409-CD51BC23-5E95-4C1D-9222-0F448FD64D7D

P2860

NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.

http://www.wikidata.org/entity/Q37018606

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@en

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@nl

type

label

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@en

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@nl

prefLabel

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@en

NF-κB and androgen receptor va ...... ms and confer 5ARI resistance.

@nl

P1433

Q37018606-DBF655C3-F2CE-43D3-A07A-0597C87951AB

P1476

Q37018606-4741F3B5-08E6-4C2F-B100-92442F74EC5B

P2093

Q37018606-0170E59C-5B05-4E3D-87C1-07127DB36C08

Q37018606-129788B1-044D-41C0-AC66-BD3D7215B965

Q37018606-2C480888-E1A2-4773-B719-5C3AD35E1695

Q37018606-398AC0D1-EE8B-4B1A-8622-D413C9227125

Q37018606-3D590BF2-9623-4BD9-8A26-5FC002E7620C

Q37018606-651E52D2-F766-461C-8C7E-1FC4E5F550E6

Q37018606-91F115D8-C6C7-40D5-9CC7-A7922EE38AAD

Q37018606-FCE29510-0216-4CB8-8ADC-B97D0B67FBA3

P2860

Q37018606-0B6B34E2-6E5C-4DDE-A74D-B252B100E318

Q37018606-0D4A54CF-8278-4665-A6A0-E33F81F4A493

Q37018606-150CE4D6-0A3C-41B8-B879-1D93D1CCFFAD

Q37018606-1959AD87-0B3E-420E-99AC-6483832FF4B6

Q37018606-1BFA24BB-17F9-441E-B244-49757F651001

Q37018606-1D9E81E2-7F5B-46EB-A534-7DC04B6EF8E9

Q37018606-210C9A6E-195F-48FE-971D-64B077B247CA

Q37018606-218546AB-AAF3-4247-99F7-FC9FD486089B

Q37018606-29A5F322-41FA-4891-8BCD-E3264C3C652A

Q37018606-2B6CB57A-93CE-409E-992A-C45FA86C62EF

P304

Q37018606-2A1A3F86-FF8A-4B5A-B174-25A52FA371E1

P31

Q37018606-94669729-A1CD-4A32-9F32-58D3F170C14D

P356

Q37018606-F4FC1ABB-18D3-48E0-845F-0E81D757C67C

P433

Q37018606-F0A7876E-1D7F-4C22-B01B-C16C354E6CAB

P478

Q37018606-3C3CDC03-0544-4B08-960D-C13D20F1A0A4

P50

Q37018606-08FB5D79-7CD0-47F9-A34B-4062D399B564

Q37018606-92C86191-281F-4679-B064-21734B61E38D

Q37018606-AE63D25C-FEE8-49C4-8A34-6E8332E09F14

P577

Q37018606-0D399D1D-C6A2-4D44-915E-8E4863C16540

P698

Q37018606-DD9C54D2-91E2-4A3A-9B73-02FBF91B9DC6

P921

Q37018606-3CF43990-DEAB-4D8D-AD79-2E03F61592E2

P932

Q37018606-403B6979-F3E6-4FB0-9CE2-7936FC5042EE

P356

P1433

P1476

NF-κB and androgen receptor va ...... rms and confer 5ARI resistance

@en

P2093

David C Austin

http://www.w3.org/2001/XMLSchema#string

Harold L Love

http://www.w3.org/2001/XMLSchema#string

Nicole L Miller

http://www.w3.org/2001/XMLSchema#string

Omar E Franco

http://www.w3.org/2001/XMLSchema#string

Omar Hameed

http://www.w3.org/2001/XMLSchema#string

Peter E Clark

http://www.w3.org/2001/XMLSchema#string

Ren J Jin

http://www.w3.org/2001/XMLSchema#string

Robert J Matusik

http://www.w3.org/2001/XMLSchema#string

P2860

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer

SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Role of the TMPRSS2-ERG gene fusion in prostate cancer

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

P304

1004-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23195

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Simon W. Hayward

Douglas W. Strand

Magdalena M Grabowska

P577

2016-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27197599

http://www.w3.org/2001/XMLSchema#string

P921

P932

4912960

http://www.w3.org/2001/XMLSchema#string